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Effect of Fasting on the Toxicity and Serum Concentration of Amino- 
pyrine in Rats. CORNISH, HERBERT H., MORRISON, A. B., and NELSON, 
JOHN M. (1970). Toxicol. Appl. Pharmacol. 17,217-222. The acute oral tox- 
icity of aminopyrine is considerably greater in the fasted rat than in the fed 
rat. Acute toxicity by the ip route was comparable in these two groups of 
animals. Serum aminopyrine concentrations in the fasted rat reached 
maximum values within 5 min after oral dosing compared with approxi- 
mately 15 min after dosing in the fed (ad libitum) animals. Maximum serum 
aminopyrine concentrations in the fasted rats were more than double those 
of the fed animals, thus accounting for the increased acute toxicity of this 
compound in fasted animals. These data not only indicate the importance of 
serum concentrations in toxicity studies, but also emphasize the necessity 
for consideration of the short-term nutritional status of the animals used in 
toxicologic investigations. 
There are reports in the literature which demonstrate that fasting inhibits N-demethyla- 
tion in the rat liver microsomal enzyme system. After 16 hr of fasting this activity was 
reported to be essentially zero (Roth and Bukovsky, 1961). If the metabolic fate of 
compounds that are metabolized by the microsomal enzyme systems can be altered by 
such a short period of fasting, then the short-term nutritional status of the animal 
assumes a most important role in toxicity testing as well as in studies of the metabolic 
fate of such compounds. Additionally, since a 24-hr fasting period is not unusual in 
many clinical situations, such findings would assume an important role in drug therapy. 
A previous report from this laboratory (Cornish and Ryan, 1965) illustrated marked 
changes in benzene metabolism in fed and fasted rats. In the present study, the effect of 
fasting on aminopyrine toxicity was investigated. 
Aminopyrine was selected for this study because its metabolic fate is well documented 
in a number of species. Brodie and Axelrod (1950) report that 4-aminoantipyrine, 
acetylaminoantipyrine, and hydroxyantipyrine are the major metabolites of amino- 
pyrine in man. Banerjee et al. (1967) recently reported on the metabolism and excretion 
of aminopyrine in normal lactating dairy cattle. As percent of the original dose, the 
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following values were found in the urine: aminopyrine, 32.4%; 4-aminoantipyrine, 
9.2 %; acetylaminoantipyrine, 24.5 %; and 4-hydroxyantipyrine, 0.57 %. The conver- 
sion of aminopyrine to 4-aminoantipyrine involves N-demethylating activity which is 
present in microsomal enzyme systems. The liver of fasted rats has been shown to have 
greatly reduced N-demethylating activity (Dixon et al., 1960). Thus the present study 
was conducted to determine the effect of fasting on the oral toxicity of aminopyrine and 
on the rate of its metabolism in viva 
METHODS 
Groups of 10 male Sprague-Dawley rats (Spartan strain) fed ad libitum were given 
geometrically graded dosages of aminopyrine. LD50 values were calculated by the 
computer program of Berkson (1944). Fed animals received commercial rat chow ad 
libitum. Other groups of rats were fasted for 24 hr before receiving the same oral doses. 
Water was allowed ad libitum to all groups. 
The LD50 values were reevaluated by the ip route to determine the role of fasting on 
the rate of aminopyrine absorption from the gastrointestinal tract. To study possible 
effects of metabolic differences in these animals, ip studies included groups of rats 
injected with &diethylaminoethyldiphenylpropylacetate hydrochloride (SKF-525-A 
75 mg/kg) 45 min prior to dosing with aminopyrine. SKF-525-A has been shown to 
inhibit at least some aspects of the microsomal drug metabolizing enzyme system (Axel- 
rod et af., 1954). 
Serum concentrations of aminopyrine and its major metabolite, 4-aminoantipyrine, 
were determined by the calorimetric method of Brodie and Axelrod (1950). For studies 
of serum concentrations, aminopyrine was given either po or ip at a dose of 200 mg/kg. 
Six animals were sacrificed at varying time intervals up to 1 hr after dosing. 
RESULTS 
All animals that died did so within a 24-hr period after dosing. Surviving animals 
were maintained for 14 days to check on latent effects. The oral and ip 1Cday LD50 
values are given in Tables 1 and 2. In fed animals, the LD50 for aminopyrine was 3044 
(2641-3508) mg/kg compared with 1576 (1252-1984) mg/kg for fasted rats. By the ip 
route, the LD50 was 251 and 261 mg/kg in fed and fasted animals respectively. In fed 
animals, pretreatment with SKF-525-A did not dramatically influence the ip LD50 (186 
mg/kg versus 251 mgfkg). Nevertheless, the range of doses causing death was much 
greater in the animals given SKF-525-A and 200 mg/kg of aminopyrine whereas no 
deaths occurred in the other two groups of rats at this dose of aminopyrine. Single 
deaths also occurred in the 158 and 126 mg/kg aminopyrine groups when the animals 
were previously dosed with SKF-525-A. 
Animals dying from aminopyrine succumbed within a relatively short period of time. 
Death was usually preceded by convulsive seizures. Hematocrits, determined on all 
animals in the 2000,2500, and 4500 mg/kg dose groups, were not significantly different 
from each other, suggesting that hemoconcentration did not play a major role in the 
mortality differences noted between fed and fasted rats. 
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Over the short period of time utilized in the present studies, the amount of the metabo- 
lite, 4-aminoantipyrine, found in the serum was not sufficient to allow for accurate 
determinations; thus only data on aminopyrine are included in this report. 
TABLE 1 
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ACUTE INTRAPERITONEAL TOXICITY OF AMINOPYRINE IN FED, FASTED, AND 
SKF-525-A TREATED RATS 
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The serum aminopyrine concentrations in the three groups of rats showed distinctly 
different patterns after the oral ingestion of aminopyrine, 200 mg/kg body weight 
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(Fig. 1). In the fasted rat, absorption was remarkably rapid, and serum concentrations 
apparently reached the peak within 5 min after dosing. The serum concentrations 
dropped rather rapidly for a short time, then more slowly over the subsequent 45-min 
period. In rather sharp contrast was the more gradual increase in serum aminopyrine in 
fed rats, a much lower peak being reached after about 15 min. In fed rats pretreated with 
SKF-525-A, serum aminopyrine levels increased somewhat more rapidly than in the fed 
animals. In all groups of animals there was little change in serum concentrations during 
the 30- to 60-min time period. 
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FIG. 1. Serum aminopyrine concentrations in fed, fasted, and SKF-525-A treated rats. Each animal 
was given an oral dose of 200 mg of aminopyrine per kilogram of body weight at zero time. SKF-525-A 
was given ip (75 mg/kg) 45 min before dosing with aminopyrine. The bar indicates one standard error. 
DISCUSSION 
The acute oral LD50 data obtained for aminopyrine in fed and fasted rats were 
markedly different. This suggested either a considerable difference in the rate of absorp- 
tion, or perhaps an altered rate or pathway of metabolism in the fasted animal. In con- 
trast to the oral LD50 data, which indicated greater toxicity of aminopyrine in the 
fasted animal, the acute ip toxicity for fed, fasted, and SKF-525-A treated animals was 
quite comparable. Thus it appeared that the dffferences in acute oral LD50 between fed 
and fasted rats were related to rates of absorption. 
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The serum aminopyrine concentrations in the three groups of rats given oral doses of 
200 mg/kg of aminopyrineconfirm this fact rather dramatically. Gastrointestinal absorp- 
tion of aminopyrine in the fasted rat was remarkably rapid, resulting in maximal blood 
levels within 5 min after dosing, when the first measurements were made. In contrast, a 
much lower peak serum level was reached approximately 15 min after ingestion in the 
fed rats. Such marked differences in absorption rates and subsequent serum concentra- 
tions could readily account for the much greater oral toxicity in the fasted rat. This 
finding emphasizes the contention of Shannon (1947), Brodie and Reid (1967), and 
others that plasma concentration rather than dosage is the critical factor in determining 
the efficacy of drugs. The same statement, of course, relates to the toxic response to 
chemical compounds. It is quite apparent, from the aminopyrine values, that the greater 
acute oral toxicity of aminopyrine in the fasted rat relates directly to its more rapid rate 
of absorption. Such findings also have a significant impact upon toxicity testing pro- 
cedures and may, at least partially, account for some interlaboratory variations in acute 
toxicity data. Although pretest treatment of animals may vary from one laboratory to 
another, it is important that the nutritional status of the animal be precisely stated. 
The rather rapid drop from peak serum aminopyrine concentrations in the fasted rat 
probably represents the period of redistribution of the high serum levels into the tissues. 
This is then followed by a rather slow rate of decrease, representing a balance between 
metabolism and excretion and the readjustment of blood: tissue ratios. The mean serum 
aminopyrine concentrations in the SKF-525-A treated rats were somewhat higher than 
those of the fed animals after oral ingestion although there was considerable overlap in 
the data on these two groups. The present findings suggest that the pharmacologic action 
of aminopyrine may be prolonged in SKF-525-A treated animals. Aminopyrine is con- 
verted by N-demethylation to 4-aminoantipyrine and then is further converted to 
N-acetyl-4-aminoantipyrine, the latter two being the major excretory products. The 
inhibitory effect of SKF-525-A on aminopyrine metabolism has been previously docu- 
mented in dogs by Axelrod et al. (1954) and in vitro in rabbit liver by Cooper et al. (1954). 
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